Thomas F. Wierzba

Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment

Vittal Mogasale, Brian Maskery, R. Leon Ochiai et al. · The Lancet Global Health · 2014 · 573 citations · Full text

Preventive Medicine, Risk-factor Adjustment, Health Economics +12

A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus Infection

Robert R. Redfield, Deborah L. Birx, Nzeera Ketter et al. · New England Journal of Medicine · 1991 · 245 citations · Full text

5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial

Sujit Bhattacharya, Dipika Sur, Mohammad Ali et al. · The Lancet Infectious Diseases · 2013 · 235 citations

Vaccination, Vaccine Safety, Vaccinology +7

Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh

Firdausi Qadri, Thomas F. Wierzba, Mohammad Ali et al. · New England Journal of Medicine · 2016 · 158 citations · Full text

Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis

John Anderson, Karoun H. Bagamian, Farzana Muhib et al. · The Lancet Global Health · 2019 · 157 citations · Full text